Lipocine Stock Market Value
| LPCN Stock | USD 3.30 0.09 2.80% |
| Symbol | Lipocine |
Lipocine Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.75) | Revenue Per Share | Quarterly Revenue Growth 137.519 | Return On Assets | Return On Equity |
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lipocine 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lipocine's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lipocine.
| 12/14/2024 |
| 03/14/2025 |
If you would invest 0.00 in Lipocine on December 14, 2024 and sell it all today you would earn a total of 0.00 from holding Lipocine or generate 0.0% return on investment in Lipocine over 90 days. Lipocine is related to or competes with Reviva Pharmaceuticals, ZyVersa Therapeutics, Unicycive Therapeutics, Checkpoint Therapeutics, Mustang Bio, Fortress Biotech, and Kodiak Sciences. Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the... More
Lipocine Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lipocine's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lipocine upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 21.22 | |||
| Value At Risk | (7.40) | |||
| Potential Upside | 5.26 |
Lipocine Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lipocine's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lipocine's standard deviation. In reality, there are many statistical measures that can use Lipocine historical prices to predict the future Lipocine's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | 0.054 | |||
| Treynor Ratio | (0.69) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lipocine's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lipocine Backtested Returns
Lipocine has Sharpe Ratio of -0.14, which conveys that the firm had a -0.14 % return per unit of risk over the last 3 months. Lipocine exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lipocine's Mean Deviation of 3.08, standard deviation of 4.08, and Risk Adjusted Performance of (0.11) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.83, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Lipocine's returns are expected to increase less than the market. However, during the bear market, the loss of holding Lipocine is expected to be smaller as well. At this point, Lipocine has a negative expected return of -0.61%. Please make sure to verify Lipocine's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Lipocine performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.50 |
Modest predictability
Lipocine has modest predictability. Overlapping area represents the amount of predictability between Lipocine time series from 14th of December 2024 to 28th of January 2025 and 28th of January 2025 to 14th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lipocine price movement. The serial correlation of 0.5 indicates that about 50.0% of current Lipocine price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.5 | |
| Spearman Rank Test | 0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 0.25 |
Lipocine lagged returns against current returns
Autocorrelation, which is Lipocine stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lipocine's stock expected returns. We can calculate the autocorrelation of Lipocine returns to help us make a trade decision. For example, suppose you find that Lipocine has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lipocine regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lipocine stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lipocine stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lipocine stock over time.
Current vs Lagged Prices |
| Timeline |
Lipocine Lagged Returns
When evaluating Lipocine's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lipocine stock have on its future price. Lipocine autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lipocine autocorrelation shows the relationship between Lipocine stock current value and its past values and can show if there is a momentum factor associated with investing in Lipocine.
Regressed Prices |
| Timeline |
When determining whether Lipocine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lipocine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lipocine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lipocine Stock:
Check out Lipocine Correlation, Lipocine Volatility and Lipocine Alpha and Beta module to complement your research on Lipocine. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Lipocine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.